Description
Tirzepatide (Dual GIP/GLP-1 Agonist) – 60 mg Kit
Includes bacteriostatic water and sterile needles for reconstitution
Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist designed to support weight management, appetite control, and glycemic regulation. By targeting both incretin pathways, Tirzepatide enhances insulin sensitivity, reduces food intake, and slows gastric emptying, making it highly effective in metabolic optimization protocols.
Clinical studies have demonstrated significant weight reduction and improved blood glucose control, with a structured titration approach improving tolerability.
This educational protocol outlines a once-weekly subcutaneous dosing strategy using a practical dilution for accurate measurement.
Kit Includes:
- Tirzepatide 60 mg (lyophilized powder)
- Bacteriostatic Water (for reconstitution)
- Sterile needles/syringes
Reconstitute:
Add 3.0 mL bacteriostatic water → ~20 mg/mL (20,000 mcg/mL) concentration
Typical Weekly Protocol (Titration):
- Week 1–4: 2.5 mg once weekly
- Week 5–8: 5 mg once weekly
- Week 9–12: 7.5 mg once weekly
- Week 13+: 10–15 mg once weekly (based on tolerance and goals)
Easy Measuring:
At 20 mg/mL,
- 1 unit = 0.01 mL ≈ 200 mcg on a U-100 insulin syringe
Example:
- 2.5 mg dose ≈ 12.5 units
- 5 mg dose ≈ 25 units
- 10 mg dose ≈ 50 units
- 15 mg dose ≈ 75 units
Administration:
- Subcutaneous injection (abdomen, thigh, or upper arm)
- Once weekly, same day each week
- Rotate injection sites for comfort
Storage:
- Lyophilized vial: Store at −20 °C (−4 °F)
- After reconstitution: Refrigerate at 2–8 °C (35.6–46.4 °F)
- Do not freeze after mixing
- Keep bacteriostatic water at room temperature before use
Note:
Tirzepatide is widely studied for obesity and type 2 diabetes management, showing strong results in fat loss, appetite suppression, and metabolic control. Common side effects may include nausea, reduced appetite, or mild gastrointestinal discomfort, particularly during dose escalation.
Reviews
There are no reviews yet.